Chromium oxide green, also known as "chromium oxide", is commonly referred to as "chromium green". Dark green hexagonal crystal or amorphous powder. Melting point 2435 ℃, boiling point 4000 ℃, relative density 5.21, refractive index 2.551. Its hydrate is commonly known as "water chromium green", which is a purple amorphous crystal or a blue-green gel like structure. Insoluble in water, acid, and alkali, soluble in hot potassium bromate solution. The property is extremely stable, and there is no change even when hydrogen gas is introduced at high temperatures. Method: It is obtained by reacting sodium dichromate with sulfur, or by heating and decomposing chromium hydroxide and ammonium dichromate. Usage: Used as a pigment, organic synthesis catalyst, ceramic glaze, paint raw material, and raw material for producing chromium alloys and chromium salts. "China has always been one of the most important markets for Canon Medical." Fujimoto Liang, president and CEO of Canon Medical Systems (China) Co., Ltd. said, "With the development strategy of 'Chinese path to modernization' and the in-depth development of the new development pattern, which focuses on the domestic big cycle and promotes domestic and international double cycles, the Chinese market continues to release huge potential. Canon Medical is full of confidence in the long-term prosperity of the Chinese market, and promoting the 'localization' strategy is one of the key points of the company's long-term development strategy. We hope to contribute to the high-quality development of China's medical industry with more localized responsibilities through the accelerated upgrading of the localization strategy."
It is understood that Canon Medical's localization strategy adopts a layout model of independent factory construction and cooperative production. Canon Medical Equipment (Dalian) Co., Ltd., established in 2018, is Canon Medical's wholly-owned production base in China, mainly producing CT equipment, magnetic resonance equipment,
Ultrasound Diagnostic Equipment, biochemical equipment and other products. At the same time, Canon Medical is also working closely with domestic manufacturers to meet the needs of Chinese users, accelerate the localization of global innovation achievements, further enrich and improve the product portfolio in the Chinese market, and help medical units at all levels in China achieve cost reduction and efficiency improvement.
Canon Medical stated that currently, multiple products in its CT, ultrasound, DSA, and biochemical product lines have been produced locally, and the domestic product lineup has begun to take shape. Among them, the GENESIS 640CT unveiled at this exhibition is the first domestically produced high-end CT product produced at Canon Medical's Dalian factory, and it is expected to achieve the first batch of deliveries in the near future. In the second half of this year, Canon Medical will also bring more domestically produced new products to the Chinese market.
In addition to local production, Canon Medical also emphasizes local innovation and local ecological development. Canon Medical said that it would further integrate the global industrial chain and innovation resources, expand cooperation with local ecosystem partners, unite with local innovation forces, promote innovation breakthroughs in advanced diagnosis and treatment technology, artificial intelligence, intelligent medical devices and other aspects, and accelerate the transformation of medical scientific and technological achievements into real productivity.
Canon Medical showcased its high-end CT equipment, magnetic resonance equipment, X-ray, angiography systems, ultrasound, biochemistry and other products, as well as customer service solutions, at the China International Medical Equipment Expo.
Facing the future, Ryo Fujimoto stated that in order to better serve Chinese users and deeply participate in the development of China's medical industry, it is necessary to firmly implement the localization strategy. Next, Canon Medical will accelerate the upgrading of its localization strategy, work together with Chinese partners to achieve win-win results, create more high-value products, and safeguard the lives and health of more people.
